Growth Metrics

Replimune (REPL) Capital Expenditures (2017 - 2025)

Replimune has reported Capital Expenditures over the past 9 years, most recently at $135000.0 for Q4 2025.

  • Quarterly results put Capital Expenditures at $135000.0 for Q4 2025, up 103.92% from a year ago — trailing twelve months through Dec 2025 was $10.6 million (up 81.31% YoY), and the annual figure for FY2025 was $6.7 million, up 18.1%.
  • Capital Expenditures reached $135000.0 in Q4 2025 per REPL's latest filing, down from $3.4 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $6.4 million in Q1 2025 and bottomed at -$3.4 million in Q4 2024.
  • Median Capital Expenditures over the past 5 years was $555000.0 (2021), compared with a mean of $950250.0.
  • Peak annual rise in Capital Expenditures hit 115300.0% in 2022, while the deepest fall reached 410.75% in 2022.
  • Over 5 years, Capital Expenditures stood at $465000.0 in 2021, then crashed by 410.75% to -$1.4 million in 2022, then crashed by 43.67% to -$2.1 million in 2023, then crashed by 65.9% to -$3.4 million in 2024, then soared by 103.92% to $135000.0 in 2025.
  • Business Quant data shows Capital Expenditures for REPL at $135000.0 in Q4 2025, $3.4 million in Q3 2025, and $645000.0 in Q2 2025.